Therapeutics

Biologics, specifically antibody therapeutics, have significant human value to fight disease.

Pipeline

Discovery
Lead Optimization
IND-Enabling Studies
Clinical

X1 Immuno-oncology

X2 Immuno-oncology

X3 Immuno-oncology

X4 Immuno-oncology

X5 Immuno-oncology

X6 Immuno-oncology

X7 Immuno-oncology

X8 Immuno-oncology

X9 Ophthalmalogy

X10 Ophthalmalogy

X11 Ophthalmalogy

X12 Ophthalmalogy

X13 Other

X14 Other

X15 Other

 

Biologics, specifically antibody therapeutics, have significant human value to fight disease. Antibody therapeutics allow for targeted correction of pathological processes, leading to mitigation or correction of disease. Five of the top ten drugs worldwide are based on monoclonal antibodies. Abpro’s antibodies, generated from our DiversImmune platform, are perfectly suited to treat disease.

We have partnered with leading companies to successfully develop many therapeutic antibodies against traditionally difficult targets. Please contact us to discuss more.

Learn more about how we can help on your therapeutics project